Holger Moch
Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
Schoenewolf N, von Moos R, Schraml P, Gillessen Sommer S, Ochsenbein A, Simcock M, Moch H, Mihic-Probst D, Dummer R, Swiss Group for Clinical Cancer Research (SAKK). Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques. Case Rep Oncol 2012; 5:280-9.
Jun 5, 2012Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques
Jun 5, 2012Case Rep Oncol 2012; 5:280-9
Schoenewolf Nicola L, von Moos Roger, Schraml Peter, Gillessen Sommer Silke, Ochsenbein Adrian, Simcock Mathew, Moch Holger, Mihic-Probst Daniela, Dummer Reinhard, Swiss Group for Clinical Cancer Research (SAKK)
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Schraml P, Moch H, Schläppi M, Seifert B, Michielin O, Dummer R, Ochsenbein A, Simcock M, Mihic-Probst D, von Teichman A, von Moos R. Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncol Rep 2012
May 18, 2012Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
May 18, 2012Oncol Rep 2012
Schraml Peter, Moch Holger, Schläppi Marc, Seifert Bettina, Michielin Olivier, Dummer Reinhard, Ochsenbein Adrian, Simcock Mathew, Mihic-Probst Daniela, von Teichman Adriana, von Moos Roger
Relevance of periostin splice variants in renal cell carcinoma
Morra L, Moch H, Schraml P, Kristiansen G, Sulser T, Diener P, Santimaria R, Duc Luu V, Casagrande S, Rechsteiner M, Soltermann A. Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol 2011; 179:1513-21.
Jul 18, 2011Relevance of periostin splice variants in renal cell carcinoma
Jul 18, 2011Am J Pathol 2011; 179:1513-21
Morra Laura, Moch Holger, Schraml Peter, Kristiansen Glen, Sulser Tullio, Diener Pierre-André, Santimaria Roger, Duc Luu Van, Casagrande Silvia, Rechsteiner Markus, Soltermann Alex
Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
Varga Z, Moch H, Jochum W, Bosshard G, Kradolfer D, Noske A, Sun Y, Wang Z, Tubbs R, Öhlschlegel C. Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer. Breast Cancer Res Treat 2011
Jun 23, 2011Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer
Jun 23, 2011Breast Cancer Res Treat 2011
Varga Zsuzsanna, Moch Holger, Jochum Wolfram, Bosshard Giovanna, Kradolfer Doris, Noske Aurelia, Sun Yang, Wang Zhen, Tubbs Raymond R, Öhlschlegel Christian
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Huber G, Züllig L, Soltermann A, Roessle M, Haerle S, Studer G, Jochum W, Moch H, Stöckli S. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC cancer 2011; 11:217:1-8.
Jun 3, 2011Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Jun 3, 2011BMC cancer 2011; 11:217:1-8
Huber Gerhard F, Züllig Lena, Soltermann Alex, Roessle Matthias, Haerle Stephan K, Studer Gabriela, Jochum Wolfram, Moch Holger, Stöckli Sandro
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma
Butsch R, Wälti S, Schaerer S, Braun J, Korol D, Probst-Hensch N, Moch H, Kurrer M. Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leuk Lymphoma 2011; 52:1230-8.
May 23, 2011Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma
May 23, 2011Leuk Lymphoma 2011; 52:1230-8
Butsch Raphael, Wälti Stephan, Schaerer Sarah, Braun Julia, Korol Dimitri, Probst-Hensch Nicole, Moch Holger, Kurrer Michael
Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients
Viehl C, Langer I, Gueller U, Zanetti-Dällenbach R, Moch H, Wight E, Oertli D, Zuber M. Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J Surg Oncol 2011; 103:531-3.
May 1, 2011Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients
May 1, 2011J Surg Oncol 2011; 103:531-3
Viehl Carsten T, Langer Igor, Gueller Ulrich, Zanetti-Dällenbach Rosanna, Moch Holger, Wight Edward, Oertli Daniel, Zuber Markus
Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma
Huber G, Albinger-Hegyi A, Soltermann A, Roessle M, Haerle S, Holzmann D, Moch H, Hegyi I. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer 2011; 117:4659-70.
Mar 29, 2011Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma
Mar 29, 2011Cancer 2011; 117:4659-70
Huber Gerhard, Albinger-Hegyi Andrea, Soltermann Alex, Roessle Matthias, Haerle Stephan K, Holzmann David, Moch Holger, Hegyi Ivan
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
Cima I, Wyler S, Zehetner J, Jochum W, Buhmann J, Cerny T, Moch H, Gillessen Sommer S, Aebersold R, Leippold T, Fuchs T, Schubert O, Schiess R, Wild P, Kaelin M, Schüffler P, Lange V, Picotti P, Ossola R, Templeton A, Krek W. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci USA 2011; 108:3342-7.
Feb 7, 2011Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
Feb 7, 2011Proc Natl Acad Sci USA 2011; 108:3342-7
Cima Igor, Wyler Stephen, Zehetner Jens, Jochum Wolfram, Buhmann Joachim, Cerny Thomas, Moch Holger, Gillessen Sommer Silke, Aebersold Ruedi, Leippold Thomas, Fuchs Thomas, Schubert Olga, Schiess Ralph, Wild Peter, Kaelin Martin, Schüffler Peter, Lange Vinzenz, Picotti Paola, Ossola Reto, Templeton Arnoud, Krek Wilhelm
Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx
Huber G, Fritzsche F, Züllig L, Storz M, K Haerle S, Jochum W, Stöckli S, Moch H. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 2010
Nov 23, 2010Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx
Nov 23, 2010Int J Cancer 2010
Huber Gerhard Frank, Fritzsche Florian R, Züllig Lena, Storz Martina, K Haerle Stephan, Jochum Wolfram, Stöckli Sandro, Moch Holger
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Langer I, Gueller U, Viehl C, Moch H, Wight E, Harder F, Oertli D, Zuber M. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Indian J Surg Oncol 2010; 1:59-67.
Aug 7, 2010Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Aug 7, 2010Indian J Surg Oncol 2010; 1:59-67
Langer Igor, Gueller Ulrich, Viehl Carsten T, Moch Holger, Wight Edward, Harder Felix, Oertli Daniel, Zuber Markus
Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC)
Albinger-Hegyi A, Moch H, Tinguely M, Rehrauer H, Probst-Hensch N, Iotzova G, Storz M, Schmid S, Stöckli S, Hegyi I. Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). Int J Cancer 2010; 126:2653-62.
Jun 1, 2010Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC)
Jun 1, 2010Int J Cancer 2010; 126:2653-62
Albinger-Hegyi Andrea, Moch Holger, Tinguely Marianne, Rehrauer Hubert, Probst-Hensch Nicole M, Iotzova Guergana, Storz Martina, Schmid Stephan, Stöckli Sandro, Hegyi Ivan
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas
Riener M, Moch H, Soltermann A, Jochum W, Clavien P, Probst-Hensch N, Pestalozzi B, Soll C, Fritzsche F, Kristiansen G. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology 2010; 56:600-6.
Apr 1, 2010Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas
Apr 1, 2010Histopathology 2010; 56:600-6
Riener Marc-Oliver, Moch Holger, Soltermann Alex, Jochum Wolfram, Clavien Pierre-Alain, Probst-Hensch Nicole, Pestalozzi Bernhard C, Soll Christopher, Fritzsche Florian R, Kristiansen Glen
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Langer I, Gueller U, Viehl C, Moch H, Wight E, Harder F, Oertli D, Zuber M. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 2009; 16:3366-74.
Sep 4, 2009Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Sep 4, 2009Ann Surg Oncol 2009; 16:3366-74
Langer Igor, Gueller Ulrich, Viehl Carsten T, Moch Holger, Wight Edward, Harder Felix, Oertli Daniel, Zuber Markus
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
Riener M, Jochum W, Moch H, Fritzsche F, Wild P, Neuhaus P, Bahra M, Clavien P, Mullhaupt B, Hellerbrand C, Probst-Hensch N, Samaras P, Pestalozzi B, Breitenstein S, Soll C, Liewen H, Stenner F, Kristiansen G. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology (Baltimore, Md.) 2009; 49:1602-9.
May 1, 2009Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
May 1, 2009Hepatology (Baltimore, Md.) 2009; 49:1602-9
Riener Marc-Oliver, Jochum Wolfram, Moch Holger, Fritzsche Florian, Wild Peter, Neuhaus Peter, Bahra Marcus, Clavien Pierre-Alain, Mullhaupt Beat, Hellerbrand Claus, Probst-Hensch Nicole, Samaras Panagiotis, Pestalozzi Bernhard Cornelius, Breitenstein Stefan, Soll Christopher, Liewen Heike, Stenner Frank, Kristiansen Glen
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
Riener M, Moch H, Clavien P, Hellerbrand C, Jungbluth A, Jin B, Knuth A, Soll C, Wild P, Jochum W. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. International journal of cancer. Journal international du cancer 2009; 124:352-7.
Jan 15, 2009Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
Jan 15, 2009International journal of cancer. Journal international du cancer 2009; 124:352-7
Riener Marc-Oliver, Moch Holger, Clavien Pierre-Alain, Hellerbrand Claus, Jungbluth Achim, Jin Boquan, Knuth Alexander, Soll Christopher, Wild Peter J, Jochum Wolfram
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study
Langer I, Zuber M, Burger D, Infanger E, Uehlinger U, Wight E, Schnarwyler B, Bronz L, Oertli D, Hess T, Fehr M, Schaer G, Moch H, Koechli O, Berclaz G, Gueller U, Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer. Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat 2008; 113:129-36.
Feb 23, 2008Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study
Feb 23, 2008Breast Cancer Res Treat 2008; 113:129-36
Langer Igor, Zuber Markus, Burger Daniel, Infanger Eduard, Uehlinger Urs, Wight Edward, Schnarwyler Beate, Bronz Lucio, Oertli Daniel, Hess Thomas, Fehr Mathias K, Schaer Gabriel, Moch Holger, Koechli Ossi R, Berclaz Gilles, Gueller Ulrich, Swiss Multicenter Study Group Sentinel Lymph Node in Breast Cancer
Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy
Langer I, Marti W, Gueller U, Moch H, Harder F, Oertli D, Zuber M. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 2005; 241:152-8.
Jan 1, 2005Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy
Jan 1, 2005Ann Surg 2005; 241:152-8
Langer Igor, Marti Walter Richard, Gueller Ulrich, Moch Holger, Harder Felix, Oertli Daniel, Zuber Markus
Human prion diseases: epidemiology and integrated risk assessment
Glatzel M, Stamm B, Podvinec M, Moch H, Huber G, Wüst W, Gmür A, Gebbers J, Linder T, Ott P, Aguzzi A. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003; 2:757-63.
Dec 1, 2003Human prion diseases: epidemiology and integrated risk assessment
Dec 1, 2003Lancet Neurol 2003; 2:757-63
Glatzel Markus, Stamm Bernhard, Podvinec Michael, Moch Holger, Huber Gerhard, Wüst Werner, Gmür Arnold, Gebbers Jan O, Linder Thomas, Ott Peter M, Aguzzi Adriano
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Gueller U, Nitzsche E, Moch H, Zuber M. Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?. J Natl Cancer Inst 2003; 95:1040-3.
Jul 16, 2003Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Jul 16, 2003J Natl Cancer Inst 2003; 95:1040-3
Gueller Ulrich, Nitzsche Egbert, Moch Holger, Zuber Markus